IM Cannabis Corp. regained compliance with Nasdaq's minimum bid price requirement on September 23, 2026, after its ordinary shares closed at $1.00 or greater for 18 consecutive business days from August 27 to September 22, 2026. The company received written notice from Nasdaq confirming the deficiency matter is now closed. IM Cannabis Corp. operates a medical cannabis platform serving patients in Israel and Germany.
